News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

West Pharmaceutical Services Announces Completion of Private Placement of Senior Debt Securities


7/6/2012 9:25:11 AM

LIONVILLE, PA--(Marketwire - July 05, 2012) - West Pharmaceutical Services, Inc. (NYSE: WST) ("West") today announced that it has completed a private placement of $168 million senior unsecured notes (the "Notes") in a private placement exempt from registration under the Securities Act of 1933, as amended. Three series of Notes were issued as follows:

                                                                            
      Series, coupon, maturity                                     Principal
-------------------------------------  -------------------------------------
                                                                            
Series 2012 A, 3.67% due July 5, 2022                            $42 million
Series 2012 B, 3.82% due July 5, 2024                            $53 million
Series 2012 C, 4.02% due July 5, 2027                            $73 million
                                                                            

The proceeds from the issuance will reduce indebtedness under West's revolving credit facility that was incurred to finance the purchase of $158.4 million aggregate principal amount of West's 4.00% Convertible Junior Subordinated Debentures due 2047, under a tender offer (the "Tender Offer") that was completed on June 5, 2012.

The weighted average of the coupon interest rates on the Notes is 3.87%. Related interest-rate hedging and transaction costs will increase the annual effective rate of interest to an estimated 4.16% for financial reporting purposes. West will provide a further update of its 2012 financial guidance, including the anticipated effects of the Tender Offer and Notes, in connection with the press release announcing its second-quarter 2012 financial results, which is tentatively scheduled for August 2, 2012.

About West

West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. West also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.


Contacts:
West
Michael A. Anderson
Vice President and Treasurer
(610) 594-3345

Investors and Financial Media:
Westwicke Partners
John Woolford / Stefan Loren
(443) 213-0506


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES